Some serious buys going through now, something is
Top 10 Most Recent News Articles
Hot Chili Sizzles with La Verde Copper Drill Gains
Big Copper Moves at La Verde: What's New? Look, when it comes to copper, Hot Chili Limited is throwing down some serious markers. You see, their La Verde project is turning into a hotbed of activity thanks to their latest drilling revelations. They've managed to confirm a second porphyry center, which is like finding another gold mine, except with copper. This essentially...
Continue Reading
Blue Moon Metals Scraps Major Acquisition Plan
Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...
Continue Reading
CMRE Facing Legal Heat Over Wage Allegations
Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...
Continue Reading
Brewers '26 Win Fuels Cap Craze: New Era's Play
Brewers: Finally on Top of the World Boy oh boy, the Milwaukee Brewers have finally done it! After years of being the underdogs, the team has clinched their first-ever World Series championship in 2026. You think you're dreaming, but no, it's the real deal. The Brewers, once just a hopeful name on the roster of Major League Baseball's teams, have stormed their way to a...
Continue Reading
Aemetis Faces Class Action Over Wage Violation Claims
California's Alert: Labor Code Violations Under Scrutiny Allegations like these can shake things up pretty quick, especially when you're dealing with harsh financial climates. Aemetis Advanced Fuel Keyes, Inc. is in hot water yet again—this time, they're being called out for allegedly messing up the wage game for their workers. That's right, a class action lawsuit filed...
Continue Reading
UBCF Strikes Big in Times Square with New Billboards
From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...
Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections
Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...
Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles
New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...
Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial
Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...
Continue Reading
PRTH Shareholder Concerns Amid Merger Investigation
Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....
Continue ReadingTop 5 Most Recently Viewed Articles
Fleet Team Appoints Marc Terwilliger as New VP for Warehousing
Marc Terwilliger Joins Fleet Team as Vice President Fleet Team, a leader in fleet management and consulting, is excited to share the news of Marc Terwilliger's appointment as Vice President of Warehouse Systems. With nearly 20 years of experience in material handling and warehousing, Marc is set to make a significant impact on innovation and operational excellence within...
Continue Reading
Zenni Optical Unveils EyeQLenz™: Panel Discussion on Innovation
Zenni Optical Launches EyeQLenz™ with Zenni ID Guard™ Zenni Optical recently introduced EyeQLenz™ with Zenni ID Guard™, an innovative lens designed to enhance eye protection and privacy. Following this exciting launch, Zenni hosted a panel discussion featuring thought leaders from technology and digital culture. This expert panel addressed how to navigate the...
Continue Reading
Empowering First-Time Homebuyers: New American Funding's Bold Launch
New Campaign Inspires First-Time Homebuyers New American Funding (NAF), a prominent independent mortgage lender, is breaking new ground with its latest campaign aimed at revitalizing the home-buying experience for the next generation. The initiative, dubbed "Hell Yeah You're Buying a Home," is designed to ignite enthusiasm and confidence in first-time homebuyers,...
Continue Reading
Projected Growth of Monk Fruit Sweeteners Market Through 2032
Monk Fruit Sweeteners Market Growth Overview The monk fruit sweeteners market is witnessing a significant transformation, spurred by health-conscious consumers seeking natural alternatives to sugar. This market is projected to experience a steady growth trajectory, reaching a remarkable $147.2 million by 2032. The expected compound annual growth rate (CAGR) is estimated...
Continue Reading
Celldex Therapeutics Secures Buy Ratings Amid Positive Data
Celldex Therapeutics (NASDAQ: CLDX) found itself in the spotlight back in 2024 when TD Cowen maintained a Buy rating on its shares following a detailed review of long-term data concerning barzolvolimab, a treatment for Chronic Spontaneous Urticaria (CSU). The standout here? The drug showcased a jaw-dropping complete response (CR) rate hitting 71% at the 52-week mark. Now...
Continue Reading